|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD显示文摘 | Casanova C Celli B R Tost L | 2000 | Chest2000，118，： | 2 |
| 2 | 为期四年的临床试验对噻托溴铵在慢性阻塞性肺疾病中的疗程评价显示文摘背景和目的:进一步观察噻托溴铵治疗COPD的长期效果。方法:通过随机、双盲试验,比较为期4年的噻托溴铵治疗COPD患者的疗效,4年期间允许患者使用除吸入抗胆碱能药物以外的任何呼吸科常用药物。要求患者年龄在40岁以上,使用支气管舒张剂后FEV1占预计值%≤70%,且FEV,/FVC占预计值%70%。主要终点是从第30天开始使用支气管舒张剂前后FEV1平均下降率。次要终点包括FVC测量值、圣乔治呼吸问卷(SGRQ)结果的变化、COPD急性加重以及病死率。结果:共入组5993例, | Tashkin DP Celli B Senn S 金建敏 孙永昌 | 2009 | 中华结核和呼吸杂志2009，32，3： | 2 |
| 3 | A 4-year trial of tiotropium in chronic obstructive pulmonary disease显示文摘 | Tashkin DP Celli B Senn S | 2008 | N Engl J Med2008，359，15： | 1 |
| 4 | Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease 显示文摘 | Calverley PM Anderson JA Celli B | 2007 | N Engl J Med2007，356，8： | 1 |
| 5 | Tiotropium HandiHal- er in the treatment of COPD : a safety review 显示文摘 | Kesten S Celli B Deeramer M | 2009 | Int J Chron Obstruct Pulmon Dis2009，4，： | 1 |
| 6 | A 4-year trial oftiotropium in chronic obstructive pulmonary disease 显示文摘 | Tashkin DP Celli B Senn S | 2008 | NEngl J Med2008，359，15： | 1 |
| 7 | Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease 显示文摘 | Celli B R Locantore N Yates J | 2012 | American journal of respiratory and critical care medicine2012，185，10： | 1 |
| 8 | Salmeterol and flutica sone propionate and survival in chronic obstructive pulmonary dis- ease显示文摘 | Calverley PM Anderson JA Celli B | 2007 | N Engl J Med2007，356，77： | 1 |
| 9 | The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease 显示文摘 | CELLI B R COTE C G MARIN J M | 2004 | N Engl J Med2004，350，10： | 1 |
| 10 | Postoperative pulmonary complications显示文摘 | Celli B R | 2001 | Med Clin North Am2001，85，5： | 1 |
| 11 | A 4-year trial of tiotropium in chronic obstructive pulmonary disease显示文摘 | Tashkin DP Celli B Senn S | 2008 | N Engl J Med2008，359，15： | 1 |
| 12 | Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease显示文摘 | Calverley PM Anderson JA Celli B | 2007 | N Engl J Med2007，356，8： | 1 |
| 13 | Bronchodilator respon- siveness in patients with COPD显示文摘 | Tashkin DP Celli B Decramer M | 2008 | Eur Respir J2008，31，4： | 1 |
| 14 | Characterisation of COPD heterogeneity in the ECLIPSE cohort 显示文摘 | Agusti A Calverley PM Celli B | 2010 | Respir Res2010，11，1： | 1 |
| 15 | The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease 显示文摘 | Celli B Cote C G Marin J M | 2004 | N Engl J Med2004，350，10： | 1 |
| 16 | Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease显示文摘 | Calverley PM Anderson JA Celli B | 2007 | N Engl J Med2007，356，8： | 1 |
| 17 | Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial 显示文摘 | Decramer M Celli B Kesten S | 2009 | Lancet2009，374，9696： | 1 |
| 18 | Salmeterol and fiutica- sone propionate and survival in chronic obstructive pulmonary disease显示文摘 | Calverley P M Anderson J A Celli B | 2007 | N Engl J Med2007，356，8： | 1 |
| 19 | Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease显示文摘 | Calvefley PM Anderson JA Celli B | | 0，，08： | 1 |
| 20 | Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes 显示文摘 | Celli B Zuwallack R Wang S | 2003 | Chest2003，124，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员